The Clinical Advisory Team at reMYND provides expert guidance on clinical trial design, implementation, and interpretation to advance the development of treatments for protein misfolding disorders. Their insights help ensure that the clinical strategies are scientifically sound and aligned with regulatory standards, thereby optimizing patient outcomes and accelerating the path to market.